Literature DB >> 29930831

Successful treatment of pulmonary contusion following chest trauma using poly-2-methoxyethyl acrylate, a biocompatible polymer surface coating for extracorporeal membrane oxygenation.

Taihei Yamada1, Takaaki Osako1, Hiroyuki Sakata1, Kazutoshi Kuboyama1, Keinichi Matsuda1, Ayana Okamoto1, Atsunori Nakao1, Joji Kotani1.   

Abstract

CASE: We report a patient with life-threatening lung contusion who was rescued using poly-2-methoxyethyl acrylate, a biocompatible polymer surface coating for extracorporeal membrane oxygenation, which enabled reduction of the dose of systemic anticoagulation to prevent circuit thrombosis. OUTCOME: A 56-year-old man was transferred to our hospital due to blunt chest trauma following a 30-m fall into water. Chest X-ray and computed tomography showed bilateral lung contusions with bilateral pneumothorax. Although drainage tubes were inserted and ventilation with positive-airway pressure was applied, PaO 2/FiO 2 remained <80 mmHg. Extracorporeal membrane oxygenation was started with heparin (5,000 units) to prevent circuit thrombosis on day 1. No significant bleeding complications or clot formation in the extracorporeal circuit were observed, with stable activated clotting time of 100-160 s without further anticoagulants.
CONCLUSION: Our case showed that poly-2-methoxyethyl acrylate-coated extracorporeal membrane oxygenation can be safely applied to patients with lung contusion associated with chest trauma.

Entities:  

Keywords:  Anticoagulation; extracorporeal membrane oxygenation; respiration; trauma; x‐coating

Year:  2013        PMID: 29930831      PMCID: PMC5997217          DOI: 10.1002/ams2.11

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


  8 in total

1.  Extracorporeal membrane oxygenation in severe trauma patients with bleeding shock.

Authors:  Matthias Arlt; Alois Philipp; Sabine Voelkel; Leopold Rupprecht; Thomas Mueller; Michael Hilker; Bernhard M Graf; Christof Schmid
Journal:  Resuscitation       Date:  2010-04-07       Impact factor: 5.262

2.  Hemocompatibility of a miniaturized extracorporeal membrane oxygenation and a pumpless interventional lung assist in experimental lung injury.

Authors:  Ruedger Kopp; Ralf Bensberg; Dietrich Henzler; Anja Niewels; Simone Randerath; Rolf Rossaint; Ralf Kuhlen
Journal:  Artif Organs       Date:  2009-10-11       Impact factor: 3.094

Review 3.  Pulmonary contusion: review of the clinical entity.

Authors:  S M Cohn
Journal:  J Trauma       Date:  1997-05

4.  Traumatic lung injury treated by extracorporeal membrane oxygenation (ECMO).

Authors:  J A Cordell-Smith; N Roberts; G J Peek; R K Firmin
Journal:  Injury       Date:  2005-10-21       Impact factor: 2.586

5.  The effects of heparin coating of oxygenator fibers on platelet adhesion and protein adsorption.

Authors:  Y Niimi; F Ichinose; Y Ishiguro; K Terui; S Uezono; S Morita; S Yamane
Journal:  Anesth Analg       Date:  1999-09       Impact factor: 5.108

6.  Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model.

Authors:  H Suhara; Y Sawa; M Nishimura; H Oshiyama; K Yokoyama; N Saito; H Matsuda
Journal:  Ann Thorac Surg       Date:  2001-05       Impact factor: 4.330

7.  Extracorporeal Life Support Organization Registry Report 2012.

Authors:  Matthew L Paden; Steven A Conrad; Peter T Rycus; Ravi R Thiagarajan
Journal:  ASAIO J       Date:  2013 May-Jun       Impact factor: 2.872

8.  Extracorporeal lung support in trauma patients with severe chest injury and acute lung failure: a 10-year institutional experience.

Authors:  Michael Ried; Thomas Bein; Alois Philipp; Thomas Müller; Bernhard Graf; Christof Schmid; David Zonies; Claudius Diez; Hans-Stefan Hofmann
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

  8 in total
  1 in total

1.  Extracorporeal membrane oxygenation in trauma patients: a systematic review.

Authors:  Changtian Wang; Lei Zhang; Tao Qin; Zhilong Xi; Lei Sun; Haiwei Wu; Demin Li
Journal:  World J Emerg Surg       Date:  2020-09-11       Impact factor: 5.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.